• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

    5.030 +0.020 (+0.40%)
    Streaming Delayed Price Updated: 10:04 AM EDT, May 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 7,182
    Open 5.040
    Bid (Size) 4.950 (4,000)
    Ask (Size) 5.040 (1,100)
    Prev. Close 5.010
    Today's Range 5.010 - 5.040
    52wk Range 1.900 - 16.56
    Shares Outstanding 620,290
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Study Suggests Testosterone Slows Glioblastoma Progression in Men
    Via Investor Brand Network
    MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports First-Quarter 2026 Results, Advances Strategic Transformation
    Via Investor Brand Network

    Performance

    YTD
    -5.1%
    -5.1%
    1 Month
    +90.5%
    +90.5%
    3 Month
    +35.9%
    +35.9%
    6 Month
    -22.0%
    -22.0%
    1 Year
    -63.6%
    -63.6%

    More News

    Read More
    News headline image
    CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
    Via ACCESS Newswire
    Blocking Fructose Metabolism Boosts Immune Response to Childhood Cancer
    Via Investor Brand Network
    Immunologists Discover How Cancer Reprograms Immune Cells to Support Cancer Growth
    Via Investor Brand Network
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures $22.5 Million Private Placement Financing
    Via Investor Brand Network
    News headline image
    CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing
    Via ACCESS Newswire
    Study Finds Exercise, Ibuprofen Combat Brain Fog in Cancer Patients
    Via Investor Brand Network
    New Molecule May Open New Therapeutic Pathway Against Brain Cancer
    Via Investor Brand Network
    Why Molecular Testing is Increasingly Important in CNS Cancers
    Via Investor Brand Network
    Scientists Discover Brain Cells That Aid Brain Cancer Development
    Via Investor Brand Network
    Preclinical Study Reveals Promising Treatment for Glioblastoma
    Via Investor Brand Network
    Study Explores Whether a Common Vitamin Could Fight Brain Cancer
    Via Investor Brand Network
    Researchers Solve 50-Year-Old Challenge in Making Cancer Drug
    Via Investor Brand Network
    Researchers Discover Mechanism Behind Deadly Pediatric Brain Cancer
    Via Investor Brand Network
    Misinformation Could Thwart the Potential of Cancer Vaccines
    Via Investor Brand Network
    Fewer Men Undergo Cancer Screening, Study Shows
    Via Investor Brand Network
    Mirror-Image Amino Acid Shows Promise in Starving Cancer Cells
    Via Investor Brand Network
    Researchers Trace Differing Pediatric Brain Tumors to Common Source
    Via Investor Brand Network
    TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Launches New Growth Strategy Focused On Neurology And Oncology Pipeline Expansion
    Via Investor Brand Network
    News headline image
    CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
    Via ACCESS Newswire
    New Research Challenges Current Thinking on How Brain Cancer Develops
    Via Investor Brand Network
    New Treatment Dramatically Improves Survival for Patients with Deadly Brain Tumors
    Via Investor Brand Network
    TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer
    Via Investor Brand Network

    Frequently Asked Questions

    Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
    CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
    What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
    The current price of CNS Pharmaceuticals, Inc. - Common Stock is 5.030
    When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 05/15/26 10:04 AM ET
    What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 3.12M
    How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
    CNS Pharmaceuticals, Inc. - Common Stock has 3M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.